Soybean isoflavones are expected to reduce the risks of various diseases. In this study, anti-allergic effects of soybean isoflavones such as genistein and daidzein, and equol, a metabolite of daidzein, were investigated by measuring the chemical mediators, leukotriene B 4 (LTB 4 ) and histamine, released from rat peritoneal exudate cells (PEC) in vitro. Genistein and equol significantly suppressed the release of LTB 4 from PEC stimulated by calcium ionophore without cytotoxicity, whereas the inhibitory effect of daidzein was weak. In contrast, they had no effect on the release of histamine from calcium ionophore-stimulated PEC. These data suggest that the soybean isoflavones and metabolite may contribute to allergy symptom relief by inhibiting leukotriene production, but not histamine release.
Introduction
The number of patients with allergic diseases shows an increasing trend in Japan. It is known that mast cells play a key role in immediate-type hypersensitivity such as food allergies and hay fever. The cell signaling in mast cells is triggered by the cross-hypersensitivity (Amin, 2012; Galli et al., 2008) . To date, antiallergy drugs such as LT receptor antagonists, 5-LOX inhibitors (Scow et al., 2007) , and histamine H1 receptor antagonists have been generally used for symptomatic treatment. In recent years, it has been expected that food components could improve allergy symptoms without side effects.
Isoflavones are a class of flavonoids that are abundant in legumes, generally as glycosides. Genistein and daidzein (Fig. 1) are the major soybean isoflavone aglycones generated because of intestinal digestion of their glycosides, genistin and daidzin, respectively. Furthermore, a part of daidzein is enzymatically metabolized to equol (Fig. 1) by intestinal bacteria. It has been suggested that genistein, daidzein, and equol are remarkable functional food components that may reduce the risks of diseases such as osteoporosis, cancer, and cardiovascular diseases (Ishimi et al., 1999; Mathey et al., 2007; Ren et al., 2001; Yamakoshi et al., 2000) . Genistein, daidzein, and equol are known to behave as phytoestrogens and antagonists by binding to estrogen receptors and G protein-coupled receptor 30 (Setchell et al., 2002; Kuiper et al., 1998; Thomas and Dong, 2006) . Anti-inflammatory or antiallergy effects of soybean isoflavones were reported by some research groups using allergic murine models (Bao et al., 2011; Masilamani et al., 2011) . Genistein and daidzein also regulated mucosal immune responses; and the effect of genistein was stronger than that of daidzein (Wei et al., 2012) . Our research group has reported that various polyphenols in foods can suppress the release of chemical mediators from rat peritoneal exudate cells (PEC) containing mast cells, rat basophilic leukemia cells (RBL−2H3), and human basophilic cells (KU812) in vitro (Matsuo et al., 1996; 1997; Tachibana et al., 2000) . These papers imply that soybean isoflavones have the potential to modulate inflammation or the allergic system. However, the anti-allergic effects of soybean isoflavones have not been sufficiently addressed. In the present study, we examined the effects of genistein, daidzein, and equol on the release of LTB 4 and histamine from rat PEC in vitro.
Materials and Methods
Materials Genistein and daidzein were purchased from Funakoshi (Tokyo, Japan). (±) Equol was obtained from Extrasynthese (Genay, France).
Preparation of PEC Rat PEC were prepared according to the method provided by Matsuo et al. (1996) . Tyrode buffer (20 mL/ rat) containing 0.1% bovine serum albumin (BSA) was injected into the peritoneal cavity of 8-week-old male Sprague−Dawley rats (Kyudo, Saga, Japan), followed by gentle massaging of the were considered statistically significant. and Gudapaty, 1993; Glaser et al., 1993) . In our experimental condition, the LTB 4 release was significantly suppressed to less than 50% by 100 µmol/L genistein, although the effect was not dose-dependent at the concentration of 1 _ 100 µmol/L. Daidzein slightly decreased LTB 4 release at 100 µmol/L. Equol significantly inhibited LTB 4 release in a dose-dependent manner at the concentration of 1 _ 100 µmol/L. These isoflavones had no cytotoxicity at 100 µmol/L for 20 min (data not shown). We had previously shown a structure−activity relationship of flavonoids such as quercetin and luteolin for the inhibition of LTB 4 production in PEC, which suggested that the C4-carbonyl group has an important role in the activities (Yamada et al., 1999) . The present data are not sufficient to reveal the structure−activity relationships of isoflavones as a LTB 4 production inhibitor. Most of genistein and daidzein exist as aglycones of genistin and daidzin at 0 _ 15 mg and 3 _ 23 mg in 100 g of dry soybean, respectively (Tsukamoto et al., 1995) . When soybean isoflavone glycosides are ingested, they are hydrolyzed to aglycones and glucose by b−glucosidase in the intestine. It has also been reported that the ingestion of 60 g of baked soybean powder increased the blood plasma level of daidzein and genistein to about 1.6 µmol/L and 2.4 µmol/L in 2 h, respectively (Watanabe et al., 1998) . Moreover, a fraction of daidzein can be metabolized to equol by enterobacterial enzymes in the intestine (Setchell et al., 1984 and 2002; Karr et al., 1997) . Setchell et al. (2002) reported that an oral dose of 25 mg of equol resulted in approximately 1.3 µmol/L of equal in the plasma in 6 h.
Results and Discussion
Our results suggest that equol, rather than daidzein and genistein, may act as a LTB 4 production inhibitor at the physiological concentration, although animal experiments need to be performed to confirm the effective concentrations in vivo. Further studies on the influences of their metabolite, especially conjugates (Thomas et al., 2001; Qiu et al., 2005) , after absorption on the inhibitory activities against LTB 4 production are also required.
We have shown that flavonoids such as epigallocatechin gallate and myricetin can inhibit histamine release from rat PEC (Matsuo et al., 1996; Yamada et al., 1999) . Several research groups have reported that eriodictyol, luteolin, and quercetin inhibited mast cell degranulation (Yoo et al., 2012; Kimata et al., 2000; Matsuda et al., 2002) . Herein, we investigated the effect of genistein, daidzein, and equol on histamine release, another chemical mediator, from calcium ionophore-stimulated rat PEC. As shown in Fig. 3 mast cells, but also macrophages and neutrophils. LTB 4 produced by neutrophils are also important in allergic skin inflammation (Oyoshi et al., 2012) . The cell type that is the target of isoflavones for anti-allergic effects will be clarified using cell lines in future studies.
In conclusion, the present data suggest that soybean isoflavones may have beneficial effects on allergy symptom relief by inhibiting LT production in mast cells. To clarify the mechanism of the antiallergic effects of soybean isoflavones, further experiments on the cell signaling pathways induced by IgE−antigen cross-linking in vitro are needed. Fig. 3 . Effect of genistein, daidzein, and equol on histamine release from rat PEC. Genistein, daidzein, or equol were added to PEC at 100 μmol/L and histamine release was induced by A23187. Histamine was determined by fluorescence photometry. Each value represents mean ± SE (n = 3 or 4).
